European Pharmaceutical Review

MAY 31, 2023

The inventory position of 28 major pharmaceutical manufacturers in 2022 has been revealed in an annual report. Yet the balance sheets of the pharmaceutical manufacturers included in the report showed limited evidence of this. Inventories grew to a combined total of $150bn in 2022, the analysis showed.

Management 111

Management Pharma Pharmaceutical manufacturing Medicine 111

Pharmaceutical Technology

SEPTEMBER 6, 2022

The pharmaceutical supply chain is a global and complex network that includes a wide range of stakeholders such as pharmaceutical manufacturers, wholesale distributors, and pharmacy benefit managers (PBM), to ensure efficient and timely delivery of medications to the patients.

Pharmaceutical 59

Pharmaceutical Leads Pharma Transportation 59

Prognos Health

SEPTEMBER 27, 2024

Breast cancer treatment is an intricate field, with ongoing research and development leading to new and innovative therapies. Ensuring that these therapies reach the right patients at the right time requires a deep understanding of the patient journey and the healthcare professionals (HCPs) involved in their care.

Pharmaceutical manufacturing 52

Pharmaceutical manufacturing Manufacturing Patients Healthcare 52

European Pharmaceutical Review

JULY 25, 2022

To appreciate the scope of the challenge facing the pharmaceutical market, as well as patients across the globe, we must understand that there are two distinct threats – ‘counterfeit’ and ‘falsified’ medicines. The latest figures suggest the pharmaceutical market is worth over $1.27 Defining ‘counterfeit’ and ‘falsified’.

Pharmaceutical 104

Pharmaceutical Medicine Manufacturing Pharmaceutical manufacturing 104

Pharmaceutical Technology

SEPTEMBER 14, 2022

Commercial dose companies form a critical component of the pharmaceutical manufacturing industry’s value chain. The dose form manufacturing follows API manufacturing to produce the final dosage form (FDF such as tablets and injectables. Discover the leading commercial dose companies in contract marketing.

Leads 40

Leads Marketing Sales Management Manufacturing 40

PM360

JUNE 26, 2023

Patients struggle to get the necessary treatments, in some cases resulting in increased hospitalization and death. The end-to-end supply chain comprises material procurement, manufacturing, transportation, warehousing, and distribution. drug manufacturers to continue producing generic drugs. Over 300 drugs in the U.S.

Manufacturing 97

Manufacturing Pharmaceutical manufacturing Pharma Management 97

pharmaphorum

AUGUST 4, 2022

For instance, in pharmaceutical manufacturing, mistakes in training can lead to contamination or waste, which can cause businesses unnecessary headaches. Lynne Byers, global managing director, Pharmaceuticals and Dietary Supplements Consulting, NSF.

Recruitment 98

Recruitment Training Pharma Pharmaceutical manufacturing 98

Prognos Health

MAY 31, 2023

Todd Somsel , Commercial Lead, RWD Marketplace The acceptance and application of real-world evidence (RWE) by stakeholders across the healthcare industry continues its rapid pace of growth. One of the key pillars of understanding is in the quality of the evidence, and its underlying real-world data (RWD).

Pharmaceutical manufacturing 52

Pharmaceutical manufacturing Specialization Manufacturing Healthcare 52

Prognos Health

MAY 31, 2023

Todd Somsel , Commercial Lead, RWD Marketplace The acceptance and application of real-world evidence (RWE) by stakeholders across the healthcare industry continues its rapid pace of growth. One of the key pillars of understanding is in the quality of the evidence, and its underlying real-world data (RWD).

Pharmaceutical manufacturing 52

Pharmaceutical manufacturing Specialization Manufacturing Healthcare 52

European Pharmaceutical Review

SEPTEMBER 29, 2022

The US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) through the Office of Pharmaceutical Quality in 2021 embarked on an initiative to develop a framework for establishing a pharmaceutical manufacturing site quality rating system, the Quality management maturity (QMM) programme.

Management 97

Management Food and Drug Administration Manufacturing Pharmaceutical manufacturing 97

PM360

NOVEMBER 14, 2023

This collaboration builds on Sanofi’s recent announcement to lower the list price for Lantus and cap OOP costs at $35 for all patients with commercial insurance, which goes into effect January 1, 2024. The price is available to cash-paying patients with a valid prescription. for only $35. Currently, an estimated 37.3 of the U.S.

Retail 52

Retail Sales Pharmaceutical manufacturing Insurance 52

Impetus Digital

AUGUST 2, 2024

The pharmaceutical industry has numerous use cases for AI. From the drug discovery phase to patient care, AI has the potential to enhance almost every stage of the product life cycle. It’s remarkable to see the progress made in the technology compared to only a few months ago and there are no signs of the progress slowing down.

Pharma 93

Pharma Manufacturing Medicine Marketing 93

PM360

OCTOBER 25, 2023

When 1+1 ≠ 2 In theory, combining two or more branded agents can lead to a price that exceeds SoC monotherapy. Call to Action Pharmaceutical manufacturers continue to push forward with active combination therapy pipelines, seeking to offer improvements over SoC in oncology. Certain markets (e.g.,

Food and Drug Administration 105

Food and Drug Administration Manufacturing Marketing Pharmaceutical manufacturing 105

eMediWrite

JULY 13, 2023

Central Drugs Standard Control Organisation (earlier known as Drugs Controller General of India) are essential to the pharmaceutical production process. They play a crucial role in assuring the efficacy and safety of products given to patients. A company’s systems transparency may also be shown by such data.

Pharmaceutical products 52

Pharmaceutical products Safety Pharmaceutical Pharmaceutical manufacturing 52

European Pharmaceutical Review

APRIL 18, 2024

Andreas Häner (AH): Roche, along with other pharmaceutical companies, acknowledges concerns about pharmaceuticals in the environment (PiE). Moreover, regulatory changes will lead to more stringent quality standards and increased reporting requirements.

Pharmaceutical 97

Pharmaceutical Manufacturing Management Doctors 97

European Pharmaceutical Review

OCTOBER 21, 2022

Ensuring products are free of contaminants has and will continue to be a vital part of the process of getting life-saving therapies to patients – the risk of causing further suffering to ailing individuals is out of the question. They can induce inflammation and fever in humans and, in rare cases, lead to anaphylactic shock and death.

Pharmaceutical manufacturing 40

Pharmaceutical manufacturing Manufacturing Leads Pharmaceutical 40

Clarify Health

OCTOBER 26, 2021

By enrolling participants with a wide range of baseline characteristics, study populations will more accurately reflect the patients likely to take the drug if it is approved. Cancer patients treated in clinical trials live substantially longer than those not treated in trials and benefit from lower hospital readmissions. 2] Figure 1.

Food and Drug Administration 52

Food and Drug Administration Recruitment Pharmaceutical manufacturing Medical 52

European Pharmaceutical Review

DECEMBER 21, 2022

2 However, most of these efforts relating to catalysis, 3 process waste metrics, 4 lifecycle assessments, 5 pharmaceuticals in the environment 6 and the phase out of substances of concern 7 mainly mitigate the consequences of pharmaceutical manufacturing. Green Chemistry in the Synthesis of Pharmaceuticals.

Manufacturing 97

Manufacturing Pharmaceutical Healthcare Healthcare 97

pharmaphorum

NOVEMBER 25, 2022

Marcello Cattani, country lead and president and managing director, Italy & Malta, at Sanofi, as well as president of Farmindustria, spoke next, expressing that he couldn’t have been happier to be in attendance for the occasion. Going beyond the standards of care; improving drug safety and efficacy.

Pharmaceutical 98

Pharmaceutical Manufacturing Medicine Competition 98

Pharmaceutical Technology

AUGUST 3, 2022

The discovery of a new chemical entity (NCE) that could potentially lead the way to a ground-breaking therapeutic treatment is an exciting prospect for any chemist. The potential to use these scientific breakthroughs to make a real difference to patients’ lives is what drives many highly skilled scientists to the world of drug development.

Pharmaceutical manufacturing 52

Pharmaceutical manufacturing Safety Pharmaceutical Manufacturing 52

PM360

JANUARY 24, 2025

AI supports marketers in key areas such as personalized campaigns (with tailored messages to healthcare professionals (HCPs) and patients), predictive analytics, and social sentiment analysis. Respondents cite workflow automation, data analysis, and realtime content generation as areas of interest within their organizations.

Marketing 64

Marketing Pharmaceutical Pharma Sales pitches 64

European Pharmaceutical Review

JULY 21, 2023

What are the top three supply-related challenges facing pharmaceutical manufacturers? While supply chain challenges became evident during the pandemic, several regions worldwide still face issues leading to product shortages. Additionally, Brexit has introduced uncertainty and disruption, further impacting the sector.

Pharmaceutical 98

Pharmaceutical Food and Drug Administration Transportation Manufacturing 98

PM360

SEPTEMBER 30, 2024

These advancements can enhance drug solubility and bioavailability, improve the speed to clinical trials, reduce environmental impact, and increase patient access to treatments. This not only boosts sustainability but also enhances process efficiency, leading to lower manufacturing costs and risks. REFERENCES 1.

Manufacturing 52

Manufacturing Pharma Pharmaceutical Competition 52

Pharmaceutical Technology

SEPTEMBER 15, 2022

Take Charleston, South Carolina, for example, where a growing number of medical device and pharmaceutical manufacturers, research laboratories and service companies have sprung up or settled in recent years. In mid-sized Charleston, connections and collaborations are a constant. Structured for business.

Medical 52

Medical Healthcare Healthcare Networking 52

Medico Reach

FEBRUARY 8, 2023

The global pharmaceutical manufacturing market stood at USD 405.52 The paradigm shift towards integrated, intelligent, and data-rich technologies is propelling the growth of medicines manufacturing. The Grand View Research published a report highlighting the stark growth prospects of the pharma industry. billion by 2027.

Pharma 52

Pharma Medicine Marketing Prospecting 52

Pharmaceutical Technology

JULY 28, 2022

After all, around a third of the world’s leading life sciences corporations have their headquarters in the country. Located in downtown Charleston, the Medical University of South Carolina trains approximately 3,000 students a year, with an emphasis on world-class patient care alongside groundbreaking research and innovation.

Transportation 52

Transportation Education Marketing Networking 52

pharmaphorum

SEPTEMBER 30, 2022

The move to component management has dramatic implications for pharmaceutical manufacturers. As a result, filings and other forms can be completed more quickly and accurately, leading to enhanced quality and regulatory compliance. Coupling data with documents can save hours spent on data quality control for submission documents.

Management 52

Management Pharmaceutical Marketing Pharmaceutical manufacturing 52

World of DTC Marketing

AUGUST 12, 2022

In the past 12 months, PhRMA and closely allied groups spent at least $57 million — $19 million of it since July — on TV , cable , radio , and social media ads opposing price negotiations, according to monitoring by the advocacy group Patients for Affordable Drugs. First, let’s clarify how the bill saves taxpayers billions.

Pharma 255

Pharma Retail Pharmaceutical Pharmaceutical manufacturing 255

pharmaphorum

OCTOBER 26, 2022

And just as a family business thrives on its connection to the community, Chiesi is committed to connecting to the global patient community. We try to have a very long-term orientation because we believe that aligns our objectives very well with the objectives of society and the patients we serve, and it makes us a stable business.”.

Patients 96

Patients Pharma Consulting Transportation 96

European Pharmaceutical Review

SEPTEMBER 28, 2023

According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), more than 600 essential medicines are at risk if a proposed restriction on the use of fluorinated substances, per- and polyfluoroalkyl substances (PFAS) across pharmaceutical manufacturing in the EEA, is implemented.

Pharmaceutical manufacturing 105

Pharmaceutical manufacturing Manufacturing Pharmaceutical Medicine 105

World of DTC Marketing

DECEMBER 10, 2020

SUMMARY: (JAMA) The median drug wholesale list price (as defined by Average Wholesale Price) increased by 129% from 2010-2016, while median patient out-of-pocket costs increased by 53% and median insurance payments after rebates and discounts increased by 64%. Say goodbye to all the supposed goodwill.

Insurance 181

Insurance Pharma Manufacturing Retail 181

Clarivate

MARCH 14, 2024

Nitrosamines have garnered significant attention from the pharmaceutical industry due to their detection in commonly prescribed medications for conditions like type 2 diabetes, high blood pressure, and heartburn. [1] The food sector has already initiated the publication of preliminary regulations aimed at restricting PFAS in packaging. [3].

Pharmaceutical 52

Pharmaceutical Manufacturing Food Healthcare Provider 52

PM360

AUGUST 26, 2024

Over time, as professional judgement led to experimentation to achieve the desired patient reported outcome (PRO) the need to close the loop with targeted treatment and diagnostics became more acute. Cancer detection involves measurement of biomarkers, which leads to the application of targeted therapy (which targets specific cancer cells).

Medicine 52

Medicine Food and Drug Administration Government Insurance 52

PM360

MAY 21, 2024

It’s a powerful technology that, if used correctly, can help us all reach new heights in pharmaceutical manufacturing and beyond. Fear-mongering can keep us from embracing potentially helpful technology, and rampant adoption of AI can lead to unnecessary missteps and mistakes. Both of these perspectives are equally dangerous.

Manufacturing 52

Manufacturing Pharma Education Pharmaceutical manufacturing 52

Pharmaceutical Technology

FEBRUARY 15, 2023

In an age of disruption, technology is key to enabling pharmaceutical manufacturers monitor, track and control shipments and their processes. Pharmaceutical firms are changing the way they do business; the future winners will be highly automated and digitalised.

Pharma 52

Pharma Pharmaceutical Manufacturing Medicine 52

European Pharmaceutical Review

FEBRUARY 20, 2025

The US imports a substantial volume of APIs and finished medicines, many of which are essential for patient care, meaning these tariffs could have far-reaching implications. 1 Here, we explore the potential impact of tariffs on pharmaceutical supply chains, pricing, investment and industry strategy.

Pharmaceutical 20

Pharmaceutical Manufacturing Medicine Pharmaceutical manufacturing 20